https://dataemia.com/2019/03/05/phase-iii-randomised-trial-comparing-6-vs-12-month-of-capecitabine-as-adjuvant-chemotherapy-for-patients-with-stage-iii-colon-cancer-final-results-of-the-jfmc37-0801-study/
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study